CIK 0001420720
- Non-accelerated filer
- Smaller reporting company
iBio, Inc.
Sign in to watch- Ticker
- IBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262797813
- Phone
- +1 302-355-0650
- Business address
- 600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
- Former names
- iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-07 | Maddux Randy Joe Chief Operating Officer | Sale | −37,243 | $0.68 | $25K | 271,757 |
| 2021-09-23 | Isett Thomas Francis 3rd CEO and Executive Chairman | Grant or award · Stock Option (right to buy) | +2,000,000 | 2,000,000 | ||
| 2021-08-23 | Lutz Robert Matthew See Remarks | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2021-08-23 | Maddux Randy Joe Chief Operating Officer | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2021-08-23 | Brenner Martin Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +700,000 | 700,000 | ||
| 2021-08-23 | Isett Thomas Francis 3rd CEO and Executive Chairman | Grant or award · Stock Option (right to buy) | +2,000,000 | 2,000,000 | ||
| 2021-08-23 | Clark William D Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2021-06-07 | Schimmelpennink Evert B. Director | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2021-04-30 | Isett Thomas Francis 3rd CEO and Executive Chairman | Grant or award · Stock Option (right to buy) | +3,000,000 | $1.37 | $4.1M | 3,000,000 |
| 2021-03-04 | Lutz Robert Matthew See Remarks | Grant or award | +232,000 | 232,000 | ||
| 2021-03-04 | Lutz Robert Matthew See Remarks | Grant or award · Stock Option (right to buy) | +350,000 | 350,000 | ||
| 2021-01-18 | Brenner Martin Chief Scientific Officer | Grant or award · Stock Option | +500,000 | 500,000 | ||
| 2020-12-01 | Maddux Randy Joe Chief Operating Officer | Grant or award | +309,000 | 309,000 | ||
| 2020-12-01 | Maddux Randy Joe Chief Operating Officer | Grant or award · Stock Option | +465,000 | 465,000 | ||
| 2020-10-14 | Armstrong Linda Washington Director | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2020-10-14 | Kropotova Alexandra Director | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2020-10-14 | Sender Gary Director | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2020-08-11 | Eastern Capital LTD 10% owner | Sale | −15,864,436 | $2.92 | $46.3M | 8,629,693 |
| 2020-08-10 | Eastern Capital LTD 10% owner | Sale | −7,264,864 | $3.91 | $28.4M | 24,494,129 |
| 2020-08-07 | Eastern Capital LTD 10% owner | Conversion | +28,925,000 | $0.20 | $5.8M | 33,114,597 |
Page 5 of 7 · 126 trades